ArticleJMIR mHealth and uHealth2025
Effects of a Transtheoretical Model-Based mHealth Intervention on Transition Readiness in Adolescents With Epilepsy: Quasi-Experimental Study.
Article in JMIR mHealth and uHealth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEnhancing self-management and transition readiness in adolescents with epilepsy is essential for successful transition to adult care. The combination of the transtheoretical model (TTM) and mobile health (mHealth) management provides a framework for reducing intervention costs while personalizing care.
objectiveThis quasi-experimental study evaluates the feasibility of TTM-based mHealth management for improving transition services in adolescents with epilepsy.
methodsA total of 98 adolescent patients with epilepsy aged 12-18 years were recruited. Using a nonrandomized design based on treatment locations, they were allocated into either the intervention group (n=49) or the control group (n=49). The intervention group received a TTM-based mHealth management program, which included phase-specific group sessions led by a multidisciplinary team and conducted via Tencent Meeting every 2 weeks or monthly (biweekly for the precontemplation, contemplation, and preparation, and monthly for the action and maintenance). The sessions involved lectures, discussions, and a mini-program that provided disease management support, motivational strategies, and digital reminders tailored to each stage. The control group received conventional remote extended care, consisting of biweekly group lectures and discussions for all patients and their families via Tencent Meeting, supplemented by regular health education materials delivered through a WeChat group. Telephone follow-ups were conducted at the third and sixth months. The total intervention duration was 6 months for both groups. Outcomes were assessed after 6 months using the self-management stage, Self-Management and Transition to Adulthood with Rx=Treatment questionnaire, and a self-developed program acceptability questionnaire.
resultsPostintervention, the intervention group demonstrated significantly better self-management behavior stages compared with controls. At the end of 6 months of intervention, the majority of participants in the intervention group reached the action stage (16/49, 32.65%) and maintenance stage (14/49, 28.57%), whereas most controls remained in precontemplation (12/49, 24.49%) and contemplation stages (13/49, 26.53%). Both groups showed significant improvements from baseline in medication management, health care participation, disease knowledge, doctor-patient communication, and transition readiness total scores at 6-month follow-up (all P<.05). Notably, the intervention group achieved additional incremental benefits versus controls (medication management: 3.81, 95% CI 1.26-6.36; health care engagement: 2.77, 95% CI 0.52-5.02; disease knowledge: 1.30, 95% CI 0.28-2.31; provider communication: 3.42, 95% CI 1.62-5.22; transition readiness: 11.30, 95% CI 5.70-6.89; effect sizes [Cohen d] ranged from 0.527 to 0.864, indicating moderate-to-large clinical effects). The overall satisfaction scores were 4.43 (SD 0.50) for patients and 4.16 (SD 0.82) for health care providers.
conclusionsThe TTM-based mHealth management program may effectively improve self-management behavior changes and enhance readiness for transition among adolescents with epilepsy, thereby facilitating a smooth transition to adult health care. The program demonstrated high acceptability, providing a reference for establishing clinical transition service protocols. However, this study was a single-center, quasi-experimental trial with a small sample size and short intervention duration. The findings need to be confirmed by larger-scale randomized controlled trials to verify efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.